The trial tests the safety and efficacy of intra-articular injections of autologous ReJoin formula in order to reduce inflammation and repair damaged joint cartilage.
http://www.biospace.com/news_story.aspx?StoryID=314437&full=1
http://www.biospace.com/news_story.aspx?StoryID=314437&full=1
No comments:
Post a Comment